Tecarfarin sodium (Synonyms: ATI-5923 sodium) |
カタログ番号GC37750 |
テカルファリン ナトリウム (ATI-5923 ナトリウム) は、ビタミン K 依存性凝固因子 II、VII、IX、および X の活性化を阻害する、新規の経口活性非競合型ビタミン K エポキシド レダクターゼ (VKOR) 拮抗薬です 。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1004551-83-0
Sample solution is provided at 25 µL, 10mM.
Tecarfarin sodium (ATI-5923 sodium) is a novel orally active non-competitive vitamin K epoxide reductase (VKOR) antagonist, impairs the activation of the vitamin K-dependent clotting factors II, VII, IX and X[1]. Tecarfarin sodium has the antithrombotic activity, attenuates venous and arterial thrombus formation in animal models by reducing the levels of the vitamin K-dependent coagulation factors[2].
[1]. Hobl EL, et al. Tecarfarin: A Novel Vitamin K Antagonist. Thromb Haemost. 2017 Nov;117(11):2009-2011. [2]. Bowersox SS, et al. Antithrombotic activity of the novel oral anticoagulant, Tecarfarin [Sodium 3-[4-((1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yloxy) carbonyl) benzyl]-2-oxo-2H-chromen-4-olate] in animal models. Thromb Res. 2010 Nov;126(5):e383-8.
Average Rating: 5
(Based on Reviews and 12 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *